2m 2m 2m 2m 2m 2m 2m
Fulgent Genetics (FLGT)
NASDAQ
$18.13-$0.57 (-3.05%)
Price as of Jun 03, 2026 4:10 PM EDT- $515.2MMarket Cap
- -11.67%1-Year Change
- Diagnostics & ResearchIndustry
Fulgent Genetics (FLGT)
$18.13-$0.57 (-3.05%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 322.7M +13.83% | 283.5M -1.99% | 289.2M -53.27% | 619.0M -37.64% | |
Cost of Revenue | 191.8M +8.82% | 176.3M -4.60% | 184.8M -26.70% | 252.1M +16.95% | |
Gross Profit | 130.9M +22.07% | 107.2M +2.64% | 104.5M -71.53% | 366.9M -52.78% | |
Sales and Marketing Expense | 43.4M +19.66% | 36.2M -12.59% | 41.5M +6.55% | 38.9M +59.25% | |
Research and Development Expense | -53.9M +10.42% | -48.8M +17.80% | -41.4M +43.34% | -28.9M +19.37% | |
Depreciation and Amortization Expense | 24.1M -3.23% | 24.9M -4.65% | 26.1M -19.96% | 32.7M +196.82% | |
Total Operating Expenses | 222.0M +22.55% | 181.1M -39.62% | 300.0M +59.25% | 188.4M +86.33% | |
Operating Profit | -91.1M +23.24% | -73.9M -62.20% | -195.5M -209.52% | 178.5M -73.59% | |
Interest Income | 30.9M -1.23% | 31.3M +45.98% | 21.4M +290.03% | 5.5M +308.17% | |
Interest Expense | N/A N/A | -300,000 +710.81% | -37,000 -89.31% | -346,000 +195.73% | |
Interest Income and Expense and Net | 30.9M -0.27% | 31.0M +44.83% | 21.4M +315.51% | 5.2M +318.86% | |
Total Nonoperating Income and Expense | 21.1M -4.06% | 22.0M +59,256.76% | 37,000 -89.31% | 346,000 +195.73% | |
Income before Taxes | -70.0M +34.78% | -52.0M -70.15% | -174.1M -194.60% | 184.0M -72.83% | |
Income Taxes | -8.4M +3.17% | -8.1M -805.03% | 1.2M -97.26% | 42.1M -75.91% | |
Extraordinary Items | 9.9M N/A | 0 N/A | N/A N/A | N/A N/A | |
Net Income | -60.5M +41.69% | -42.7M -74.55% | -167.8M -217.03% | 143.4M -71.74% | |
Net Income from Continuing Operations Applicable to Common | -70.0M +34.78% | -52.0M -70.15% | -174.1M -194.60% | 184.0M -72.83% | |
Basic EPS and Net Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Diluted EPS and Net Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Basic Weighted Average Shares | 30.8M +1.79% | 30.2M +1.51% | 29.8M -1.04% | 30.1M +2.34% | |
Diluted Weighted Average Shares | 30.8M +1.79% | 30.2M +1.51% | 29.8M -3.81% | 31.0M -0.04% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 50.2M -8.98% | 55.1M -43.43% | 97.5M +22.60% | 79.5M -51.78% | |
Short-Term Investments | 285.9M N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 336.1M +509.45% | 55.1M -43.43% | 97.5M +22.60% | 79.5M -51.78% | |
Total Current Assets | 550.5M +55.69% | 353.6M -30.38% | 507.8M -19.12% | 627.9M +2.60% | |
Accumulated Depreciation | 57.9M +12.06% | 51.7M +0.15% | 51.6M +19.30% | 43.3M +120.48% | |
Property and Plant and Equipment and Net | 112.5M +6.63% | 105.5M +26.46% | 83.5M +2.59% | 81.4M +30.61% | |
Total Long-Term Assets | 22.9M -31.69% | 33.5M -4.13% | 34.9M -20.90% | 44.1M +314.31% | |
Total Assets | 1.2B -0.53% | 1.2B -1.24% | 1.2B -10.87% | 1.4B +8.39% | |
Income Taxes Payable | 6.9M +8.89% | 6.4M -19.99% | 8.0M +911.69% | 787,000 0.00% | |
Total Short-Term Debt | 476,000 +15.53% | 412,000 -65.17% | 1.2M -79.02% | 5.6M -8.26% | |
Total Current Liabilities | 85.0M +16.55% | 72.9M -0.16% | 73.0M -17.13% | 88.1M -16.34% | |
Total Long-Term Debt | 4.4M -19.19% | 5.4M -15.26% | 6.4M -11.61% | 7.2M +18.03% | |
Total Long-Term Liabilities | 7.6M +9.34% | 7.0M -53.77% | 15.1M -17.28% | 18.2M +167.96% | |
Total Liabilities | 106.8M +17.63% | 90.8M -11.01% | 102.0M -12.17% | 116.2M +2.96% | |
Retained Earnings | 530.0M -10.25% | 590.5M -6.75% | 633.2M -20.95% | 801.0M +21.81% | |
Total Stockholders Equity | 1.1B -1.87% | 1.1B -0.25% | 1.1B -10.31% | 1.3B +9.31% | |
Total Shares Outstanding | 31.1M +0.78% | 30.8M +4.01% | 29.7M +0.73% | 29.4M -2.39% | |
Cash Flow | |||||
Cash from Operating Activities | -101.6M -582.61% | 21.1M -22.01% | 27.0M -89.35% | 253.5M -52.93% | |
Capital Expenditures | 22.6M -44.01% | 40.3M +81.54% | 22.2M +18.28% | 18.8M -21.15% | |
Cash from Investing Activities | 111.4M +290.86% | -58.4M -250.01% | 38.9M +114.89% | -261.3M -52.19% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -14.8M +205.12% | -4.8M -89.86% | -47.8M -38.05% | -77.1M -190.32% | |
Financials Ratio | |||||
Gross Margin | 40.56% +7.24% | 37.82% +4.72% | 36.12% -39.07% | 59.28% -24.28% | |
Operating Margin | -28.23% +8.27% | -26.08% -61.43% | -67.61% -334.40% | 28.84% -57.65% | |
Return on Assets | -4.97% +42.96% | -3.48% -72.83% | -12.80% -218.97% | 10.76% -79.01% | |
Return on Equity | -5.39% +43.21% | -3.76% -73.06% | -13.97% -218.13% | 11.82% -79.86% | |
Revenue Growth | 13.83% +796.43% | -1.99% -96.27% | -53.27% +41.54% | -37.64% -127.81% | |
Current Ratio | 6.48 +33.58% | 4.85 -30.27% | 6.96 -2.40% | 7.13 +22.63% | |
Cash Ratio | 0.59 -21.91% | 0.76 -43.34% | 1.33 +47.93% | 0.90 -42.37% | |
Debt-to-Equity Ratio | 0.004 -15.69% | 0.005 -22.73% | 0.007 -34.65% | 0.01 -4.72% | |
Debt-to-Assets Ratio | 0.004 -16.67% | 0.005 -21.31% | 0.006 -34.41% | 0.009 -3.12% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow